1. Home
  2. COEP vs CLPS Comparison

COEP vs CLPS Comparison

Compare COEP & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CLPS
  • Stock Information
  • Founded
  • COEP 2017
  • CLPS 2005
  • Country
  • COEP United States
  • CLPS Hong Kong
  • Employees
  • COEP N/A
  • CLPS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CLPS Computer Software: Prepackaged Software
  • Sector
  • COEP Health Care
  • CLPS Technology
  • Exchange
  • COEP Nasdaq
  • CLPS Nasdaq
  • Market Cap
  • COEP 27.4M
  • CLPS 26.0M
  • IPO Year
  • COEP N/A
  • CLPS 2018
  • Fundamental
  • Price
  • COEP $8.28
  • CLPS $0.92
  • Analyst Decision
  • COEP
  • CLPS
  • Analyst Count
  • COEP 0
  • CLPS 0
  • Target Price
  • COEP N/A
  • CLPS N/A
  • AVG Volume (30 Days)
  • COEP 33.0K
  • CLPS 12.0K
  • Earning Date
  • COEP 08-15-2025
  • CLPS 03-05-2025
  • Dividend Yield
  • COEP N/A
  • CLPS 14.23%
  • EPS Growth
  • COEP N/A
  • CLPS N/A
  • EPS
  • COEP N/A
  • CLPS N/A
  • Revenue
  • COEP $62,874.00
  • CLPS $153,816,045.00
  • Revenue This Year
  • COEP N/A
  • CLPS N/A
  • Revenue Next Year
  • COEP N/A
  • CLPS N/A
  • P/E Ratio
  • COEP N/A
  • CLPS N/A
  • Revenue Growth
  • COEP N/A
  • CLPS 5.81
  • 52 Week Low
  • COEP $2.31
  • CLPS $0.68
  • 52 Week High
  • COEP $13.70
  • CLPS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • COEP 50.63
  • CLPS 42.59
  • Support Level
  • COEP $7.25
  • CLPS $0.90
  • Resistance Level
  • COEP $8.86
  • CLPS $0.94
  • Average True Range (ATR)
  • COEP 0.60
  • CLPS 0.05
  • MACD
  • COEP 0.06
  • CLPS -0.00
  • Stochastic Oscillator
  • COEP 71.77
  • CLPS 25.90

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

Share on Social Networks: